The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Doxercalciferol Market Research Report 2024
Synopsis
Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease. It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.
The global Doxercalciferol market was valued at US$ 354 million in 2023 and is anticipated to reach US$ 521.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Doxercalciferol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Doxercalciferol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Doxercalciferol include Sanofi, Prasco Laboratories, Hikma Pharmaceuticals, Amneal Pharms, Pfizer, Akorn and West-Ward Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Doxercalciferol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doxercalciferol.
Report Scope
The Doxercalciferol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Doxercalciferol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doxercalciferol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Prasco Laboratories
Hikma Pharmaceuticals
Amneal Pharms
Pfizer
Akorn
West-Ward Pharmaceuticals
Segment by Type
Injection
Capsule
Segment by Application
SHPT in patients with CKD on dialysis
SHPT in patients with stage 3 or stage 4 CKD
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Doxercalciferol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Doxercalciferol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Doxercalciferol (or 1-hydroxyergocalciferol, trade name Hectorol) is drug for secondary hyperparathyroidism and metabolic bone disease. It is a synthetic analog of ergocalciferol (vitamin D2). It suppresses parathyroid synthesis and secretion.
The global Doxercalciferol market was valued at US$ 354 million in 2023 and is anticipated to reach US$ 521.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Doxercalciferol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Doxercalciferol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Doxercalciferol include Sanofi, Prasco Laboratories, Hikma Pharmaceuticals, Amneal Pharms, Pfizer, Akorn and West-Ward Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Doxercalciferol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Doxercalciferol.
Report Scope
The Doxercalciferol market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Doxercalciferol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Doxercalciferol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Prasco Laboratories
Hikma Pharmaceuticals
Amneal Pharms
Pfizer
Akorn
West-Ward Pharmaceuticals
Segment by Type
Injection
Capsule
Segment by Application
SHPT in patients with CKD on dialysis
SHPT in patients with stage 3 or stage 4 CKD
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Doxercalciferol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Doxercalciferol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Doxercalciferol Market Overview
1.1 Product Overview and Scope of Doxercalciferol
1.2 Doxercalciferol Segment by Type
1.2.1 Global Doxercalciferol Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Capsule
1.3 Doxercalciferol Segment by Application
1.3.1 Global Doxercalciferol Market Value by Application: (2024-2030)
1.3.2 SHPT in patients with CKD on dialysis
1.3.3 SHPT in patients with stage 3 or stage 4 CKD
1.4 Global Doxercalciferol Market Size Estimates and Forecasts
1.4.1 Global Doxercalciferol Revenue 2019-2030
1.4.2 Global Doxercalciferol Sales 2019-2030
1.4.3 Global Doxercalciferol Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Doxercalciferol Market Competition by Manufacturers
2.1 Global Doxercalciferol Sales Market Share by Manufacturers (2019-2024)
2.2 Global Doxercalciferol Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Doxercalciferol Average Price by Manufacturers (2019-2024)
2.4 Global Doxercalciferol Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Doxercalciferol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Doxercalciferol, Product Type & Application
2.7 Doxercalciferol Market Competitive Situation and Trends
2.7.1 Doxercalciferol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Doxercalciferol Players Market Share by Revenue
2.7.3 Global Doxercalciferol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Doxercalciferol Retrospective Market Scenario by Region
3.1 Global Doxercalciferol Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Doxercalciferol Global Doxercalciferol Sales by Region: 2019-2030
3.2.1 Global Doxercalciferol Sales by Region: 2019-2024
3.2.2 Global Doxercalciferol Sales by Region: 2025-2030
3.3 Global Doxercalciferol Global Doxercalciferol Revenue by Region: 2019-2030
3.3.1 Global Doxercalciferol Revenue by Region: 2019-2024
3.3.2 Global Doxercalciferol Revenue by Region: 2025-2030
3.4 North America Doxercalciferol Market Facts & Figures by Country
3.4.1 North America Doxercalciferol Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Doxercalciferol Sales by Country (2019-2030)
3.4.3 North America Doxercalciferol Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Doxercalciferol Market Facts & Figures by Country
3.5.1 Europe Doxercalciferol Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Doxercalciferol Sales by Country (2019-2030)
3.5.3 Europe Doxercalciferol Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Doxercalciferol Market Facts & Figures by Country
3.6.1 Asia Pacific Doxercalciferol Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Doxercalciferol Sales by Country (2019-2030)
3.6.3 Asia Pacific Doxercalciferol Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Doxercalciferol Market Facts & Figures by Country
3.7.1 Latin America Doxercalciferol Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Doxercalciferol Sales by Country (2019-2030)
3.7.3 Latin America Doxercalciferol Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Doxercalciferol Market Facts & Figures by Country
3.8.1 Middle East and Africa Doxercalciferol Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Doxercalciferol Sales by Country (2019-2030)
3.8.3 Middle East and Africa Doxercalciferol Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Doxercalciferol Sales by Type (2019-2030)
4.1.1 Global Doxercalciferol Sales by Type (2019-2024)
4.1.2 Global Doxercalciferol Sales by Type (2025-2030)
4.1.3 Global Doxercalciferol Sales Market Share by Type (2019-2030)
4.2 Global Doxercalciferol Revenue by Type (2019-2030)
4.2.1 Global Doxercalciferol Revenue by Type (2019-2024)
4.2.2 Global Doxercalciferol Revenue by Type (2025-2030)
4.2.3 Global Doxercalciferol Revenue Market Share by Type (2019-2030)
4.3 Global Doxercalciferol Price by Type (2019-2030)
5 Segment by Application
5.1 Global Doxercalciferol Sales by Application (2019-2030)
5.1.1 Global Doxercalciferol Sales by Application (2019-2024)
5.1.2 Global Doxercalciferol Sales by Application (2025-2030)
5.1.3 Global Doxercalciferol Sales Market Share by Application (2019-2030)
5.2 Global Doxercalciferol Revenue by Application (2019-2030)
5.2.1 Global Doxercalciferol Revenue by Application (2019-2024)
5.2.2 Global Doxercalciferol Revenue by Application (2025-2030)
5.2.3 Global Doxercalciferol Revenue Market Share by Application (2019-2030)
5.3 Global Doxercalciferol Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Doxercalciferol Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Prasco Laboratories
6.2.1 Prasco Laboratories Corporation Information
6.2.2 Prasco Laboratories Description and Business Overview
6.2.3 Prasco Laboratories Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Prasco Laboratories Doxercalciferol Product Portfolio
6.2.5 Prasco Laboratories Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporation Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hikma Pharmaceuticals Doxercalciferol Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Amneal Pharms
6.4.1 Amneal Pharms Corporation Information
6.4.2 Amneal Pharms Description and Business Overview
6.4.3 Amneal Pharms Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Pharms Doxercalciferol Product Portfolio
6.4.5 Amneal Pharms Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Doxercalciferol Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Akorn
6.6.1 Akorn Corporation Information
6.6.2 Akorn Description and Business Overview
6.6.3 Akorn Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Akorn Doxercalciferol Product Portfolio
6.6.5 Akorn Recent Developments/Updates
6.7 West-Ward Pharmaceuticals
6.6.1 West-Ward Pharmaceuticals Corporation Information
6.6.2 West-Ward Pharmaceuticals Description and Business Overview
6.6.3 West-Ward Pharmaceuticals Doxercalciferol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West-Ward Pharmaceuticals Doxercalciferol Product Portfolio
6.7.5 West-Ward Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Doxercalciferol Industry Chain Analysis
7.2 Doxercalciferol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Doxercalciferol Production Mode & Process
7.4 Doxercalciferol Sales and Marketing
7.4.1 Doxercalciferol Sales Channels
7.4.2 Doxercalciferol Distributors
7.5 Doxercalciferol Customers
8 Doxercalciferol Market Dynamics
8.1 Doxercalciferol Industry Trends
8.2 Doxercalciferol Market Drivers
8.3 Doxercalciferol Market Challenges
8.4 Doxercalciferol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
